NCD Alliance Advocacy Briefing for World Health Organization 146th Executive Board 2020 (EB146)

Published	28th January 2020
Author	NCD Alliance
Download	Document (308.60kB)

Description

This briefing note provides an overview of the NCD Alliance’s advocacy priorities for the 146th Session of the World Health Organization's Executive Board in February 2020. Statements submission in conjunction with other organisations will be uploaded to our website to coincide with EB146.

executive board, advocacy

Tag Feed: WHO Executive Board

NCD Alliance Advocacy Briefing on the 154th Session of the WHO Executive Board (EB154) - 22 January – 27 January 2024

16th January 2024

This briefing note provides background and key advocacy messages on the noncommunicable disease (NCD) community’s priorities for the 154th session of the WHO Executive Board (EB154), covering NCD-relevant items on the provisional agenda (EB154/1 annotated).
154th WHO Executive Board

15th January 2024

Advocacy briefings and other resources to support your WHO Executive Board activities in January 2024.
WHO Executive Board: Member States’ support for fighting NCDs not echoed in current UHC decision

14th February 2023

There is an inconsistency in acknowledging that addressing NCDs is crucial to achieve UHC and not mentioning it in the current WHO decision towards the UN high-level meeting.
NCD Alliance enters into official relations with the WHO

06th February 2023

Today, at the 152nd session of the Executive Board meetings, the 34 members of the World Health Organization (WHO) Executive Board voted to grant the NCD Alliance (NCDA) official relations status with WHO.
WHO EB 152 Agenda Item 6 Joint Statement with Union for International Cancer Control (UICC)

01st February 2023

This is a joint statement by NCD Alliance and Union for International Cancer Control (UICC) on agenda item 6: Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases, and mental health - EB152.